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Summary
Kainate receptors (KARs) have been shown to be in-
volved in hippocampal mossy fiber long-term potenti-
ation (LTP); however, it is not known if KARs are in-
volved in the induction or expression of long-term
depression (LTD), the other major form of long-term
synaptic plasticity. Here we describe LTD of KAR-me-
diated synaptic transmission (EPSCKA LTD) in perirhi-
nal cortex layer II/III neurons that is distinct from LTD
of AMPAR-mediated transmission, which also coex-
ists at the same synapses. Induction of EPSCKA LTD
requires a rise in postsynaptic Ca2+ but is independent
of NMDARs or T-type voltage-gated Ca2+ channels;
however, it requires synaptic activation of inwardly
rectifying KARs and release of Ca2+ from stores. The
synaptic KARs are regulated by tonically activated
mGluR5, and expression of EPSCKA LTD occurs via
a mechanism involving mGluR5, PKC, and PICK1
PDZdomain interactions. Thus, we describe the induc-
tion and expression mechanism of a form of synaptic
plasticity, EPSCKA LTD.
Introduction
KARs are a subfamily of ionotropic glutamate receptors
that are known to be localized both pre- and postsynap-
tically at synapses in the mammalian central nervous
system (Watkins and Evans, 1981; Hollmann and Heine-
mann, 1994; Bahn et al., 1994). To date, five KAR sub-
units (GluR5, GluR6, GluR7, KA1, and KA2) have been
identified in the CNS (Bettler et al., 1990; Wisden and
Seeburg, 1993; Chittajallu et al., 1999; Contractor
et al., 2000). KARs are involved in synaptic transmission,
both postsynaptically, where they mediate slow synap-
tic responses, and also presynaptically, by regulating
*Correspondence: k.cho@sheffield.ac.ukglutamate or GABA release (Lerma, 2003; Isaac et al.,
2004). KARs are widely expressed in the mammalian
brain and are implicated in neurological diseases such
as epilepsy (e.g., Mulle et al., 1998; Smolders et al.,
2002).
Recent studies have demonstrated that KARs are in-
volved in long-term synaptic plasticity. In the hippocam-
pus, KARs are important for the induction of long-term
potentiation (LTP) at mossy fiber-CA3 synapses (Borto-
lotto et al., 1999; Contractor et al., 2001; Lauri et al.,
2001; Schmitz et al., 2003), a form of LTP thought to be
presynaptic in its induction and expression (Nicoll and
Malenka, 1995). At thalamocortical synapses in the neo-
natal barrel cortex, LTP expression is associated with
a reduction in the KAR-mediated component to trans-
mission (Kidd and Isaac, 1999). However, it is not known
if KARs are involved in long-term depression (LTD), the
other major form of activity-dependent long-term syn-
aptic plasticity in the mammalian brain. Recent evidence
suggests that mechanisms exist for the rapid differential
regulation of AMPAR and KAR function by interacting
proteins at the same population of synapses (Hirbec
et al., 2003). This provides the potential for the indepen-
dent postsynaptic regulation of KARs, although whether
this mechanism is involved in synaptic plasticity is not
known.
Here we have investigated KARs at synapses on layer
II/III neurons in perirhinal cortex. We show that a form
of LTD of the KAR-mediated EPSC (EPSCKA) can be
induced that is independent of the previously charac-
terized LTD of EPSCAMPA at the same inputs. LTD of
EPSCKA has rather precise frequency requirements, be-
ing induced by 5 Hz afferent stimulation but not by 1 or
10 Hz stimulation. EPSCKA LTD requires a rise in post-
synaptic Ca2+ but is independent of NMDARs and
voltage-gated Ca2+ channels. This form of LTD does,
however, require KAR activation and is expressed via
a mechanism involving mGluR5, PKC, and PICK1 PDZ
domain interactions. Thus KAR-mediated synaptic
transmission can undergo a form of LTD that is mecha-
nistically distinct from the coexisting LTD of AMPAR-
mediated transmission at these inputs.
Results
LTD of EPSCKA Can Be Induced in Layer II/III
Perirhinal Cortical Neurons
Kainate receptor-mediated EPSCs (EPSCKA) can be
evoked in layer II/III neurons in perirhinal cortex slices
using brief trains of high-frequency stimulation (five
stimuli at 50 or 100 Hz) of the entorhinal input (Cho
et al., 2003; Figure 1A). Similar to EPSCKA evoked at
mossy fiber-CA3 synapses in hippocampus (Castillo
et al., 1997; Vignes and Collingridge, 1997), the KAR-
dependent component of the synaptic response can
be isolated in the presence of the GABAA receptor an-
tagonist picrotoxin (20 mM), the NMDA receptor antago-
nist D-AP5 (50 mM), and the selective AMPA receptor an-
tagonist GYKI53655 (50 mM) and is fully blocked by the
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96Figure 1. LTD of KAR-Mediated EPSCs in Layer II/III Perirhinal Cortical Neurons
(A) Positioning of stimulating electrodes in perirhinal cortex slice (upper panel) and pharmacologically isolated EPSCKA evoked by five stimuli at
50 Hz, in the presence of 20 mM picrotoxin plus 50 mM AP5 (lower trace); picrotoxin, AP5, and 50 mM GYKI53655 (middle trace); and picrotoxin,
AP5, GYKI53655 plus 25 mM CNQX (upper trace). EPSCKA measured 110–120 ms after the last stimulus in the train (indicated by arrows in [B]), and
EPSCAMPA measured as the peak of the first response (indicated by arrows in [C]).
(B) Pooled data and corresponding example traces for EPSCKA for two pathway experiments showing pathway-specific induction of LTD of
EPSCKA by 200 stimuli at 5 Hz (270 mV holding potential) at the entorhinal input (closed circles represent test entorhinal pathway; open circles
represent control temporal pathway).
(C) Pooled data and corresponding example traces for EPSCAMPA experiments showing pathway-specific induction of LTD of EPSCAMPA by
200 stimuli at 5 Hz (270 mV holding potential) at the entorhinal input. Open circles represent control temporal pathway.
(D) Pooled data and corresponding example traces for pharmacologically isolated EPSCKA experiments (in the presence of 50 mM GYKI53655)
showing pathway-specific induction of LTD of EPSCKA by 200 stimuli at 5 Hz (270 mV holding potential) at the entorhinal input. Open circles
represent control temporal pathway.
Error bars indicate SEM.nonselective AMPA receptor and KAR antagonist CNQX
(25 mM). Thus, EPSCKA exhibits similar pharmacology to
that previously reported at other synapses (Lerma et al.,
2001). We first investigated whether activity can induce
long-term synaptic plasticity of EPSCKA in two-pathway
experiments in which a second control (temporal) input
was also monitored (Cho et al., 2000). We measured the
fast AMPAR-mediated and the late slow KAR-mediated
components of the dual component EPSC in the same
cells. Two hundred afferent stimuli at 5 Hz (voltage clamp
at270 mV) applied to the test (entorhinal) input induced
an LTD of EPSCKA (67% 6 4% of baseline, n = 10, Fig-
ure 1B) and of EPSCAMPA (63%6 4% of baseline, n = 10,
Figure 1C). This depression was input specific, since
no LTD was observed in the nonconditioned temporal
input. We next determined if LTD of EPSCKA could be ob-
served in pharmacologically isolated KAR-mediated
EPSCs. Thus, in another set of experiments, the LTD in-
duction protocol was applied in the presence of 50 mM
GYKI53655 and 50 mM AP5. Under these conditions, arobust LTD of EPSCKA was observed (67% 6 3%, n = 8,
Figure 1D). This LTD was not associated with any change
in the decay kinetics of EPSCKA (baseline = 1376 12 ms,
LTD = 1346 13 ms, n = 8, p > 0.05). The ability to induce
LTD in the pharmacologically isolated EPSCKA (in the
presence of AP5) demonstrates that, unlike LTD of
EPSCAMPA (Cho et al., 2000), this form of plasticity does
not require NMDAR activation.
The lack of NMDAR dependence for EPSCKA LTD
suggests that this is a form of plasticity that is mechanis-
tically distinct from the previously described LTD of
EPSCAMPA at this input (Cho et al., 2000). We therefore
investigated whether the two forms require different fre-
quencies of stimulation for induction. An induction pro-
tocol of 200 stimuli at 1 Hz, a frequency that induces
NMDAR-dependent LTD of EPSCAMPA at this input
(63%6 5%, n = 8; see also Cho et al., 2000), failed to de-
press EPSCKA (95%6 4%, n = 8 in EPSCKA, Figure 2A) in
the same cells. Moreover, using the pharmacologically
isolated EPSCKA, 1 Hz stimulation failed to induce LTD of
LTD of the KA Receptor-Mediated EPSC
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tion Frequency Requirements from EPSCAMPA
LTD
(A) 200 stimuli at 1 Hz (270 mV holding po-
tential) induces LTD of EPSCAMPA but not
EPSCKA.
(B and C) Stimulation (5 Hz) in the presence of
GKYI53655 and AP5 results in induction of
LTD of EPSCKA. Pooled data for the effects
of a 1 Hz (B) or a 10 Hz (C) 200 stimulus pro-
tocol on EPSCKA. Neither 1 Hz nor 10 Hz stim-
ulation is able to induce LTD of EPSCKA, but
5 Hz stimulation induces LTD in the same
neurons. Filled symbols indicate test path-
way.
(D) Summary graph showing the effects of
various induction protocols on EPSCKA.EPSCKA (98% 6 4%, n = 6; Figure 2B), but, in the same
neurons,5 Hz stimulation induced robust LTD (75%64%,
n = 6). We also investigated higher frequencies for in-
duction of EPSCKA LTD. Two hundred stimuli at 10 Hz
failed to induce LTD of EPSCKA (101% 6 5%, n = 8, Fig-
ure 2C), although, in the same neurons, 5 Hz stimulation
reliably induced LTD. Finally, we tested whether dou-
bling the number of stimuli at 1 or 10 Hz could induce
LTD; however, 400 stimuli at 1 or 10 Hz failed to induce
any depression (Figure 2D). Thus, LTD of EPSCKA re-
quires a restricted frequency of stimulation for induction
(w5 Hz) and is independent of LTD of AMPAR-mediated
synaptic transmission.LTD of EPSCKA Requires a Rise in Postsynaptic
Calcium Concentration
We next investigated the role of Ca2+ in EPSCKA LTD. In-
clusion of the Ca2+ chelator BAPTA (10 mM) in the elec-
trode solution blocked LTD of EPSCKA (94%6 4%, n = 8,
Figure 3A). To further determine the role of Ca2+ in LTD
of EPSCKA, we tested the effects of reducing extracellu-
lar Ca2+ concentration ([Ca2+]ex). Bathing slices in 1 mM
[Ca2+]ex prevented the induction of LTD by 5 Hz stimula-
tion (101% 6 9%, n = 8, Figure 3B); however, on return-
ing to control levels of [Ca2+]ex (2 mM), the 5 Hz stimula-
tion induced LTD in the same neurons (73%6 7%, n = 8,
Figure 3B). This suggests that Ca2+ influx across the
Neuron
98Figure 3. Postsynaptic Ca2+ Is Required for
LTD of EPSCKA
(A) Pooled data showing the effects of post-
synaptic BAPTA on LTD of EPSCKA. Postsyn-
aptic addition of 10 mM BAPTA blocks LTD of
EPSCKA.
(B) Pooled data for the effects of changing
extracellular Ca2+ concentration on LTD of
EPSCKA. Stimulation (5 Hz) in the presence
of 1 mM extracellular Ca2+ fails to induce
LTD, but LTD is induced with 2 mM extracel-
lular Ca2+ in the same cells. Arrow at 60 min
time (RN) indicates a renormalization of the
baseline.
(C) Pooled data for the effects of postsynap-
tic CPA (2 mM) on EPSCKA LTD.
(D) Pooled data for the effect of 100 mM NiCl2
on LTD of EPSCKA.plasma membrane in the postsynaptic neuron is re-
quired for induction of EPSCKA LTD. Since NMDARs
are not required for this form of LTD, we investigated
other sources for the Ca2+ influx. We next determined
the role of intracellular Ca2+ stores in EPSCKA LTD. Post-
synaptic inclusion of cyclopiazonic acid (CPA; 2 mM),
which depletes calcium stores, blocked LTD of EPSCKA
(96% 6 7%, n = 6, Figure 3C). Previous work demon-
strates that T-type Ca2+ channels are involved in oneform of hippocampal LTD (Oliet et al., 1997). However,
bath application of 100 mM Ni2+, which selectively blocks
this channel type, had no effect on 5 Hz-induced LTD of
EPSCKA (70% 6 7%, n = 7, Figure 3D).
Induction of EPSCKA LTD Requires the Activation
of KARs
Since LTD of EPSCKA requires a rise in postsynaptic
Ca2+ but does not require NMDAR, T-type calcium
LTD of the KA Receptor-Mediated EPSC
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may require KAR activation. Therefore, we used phar-
macologically isolated EPSCKA (in the presence of picro-
toxin, GYKI53655, AP5) and, following collection of
a baseline, applied the nonselective AMPA and KAR
antagonist CNQX (5 mM). A subsaturating dose that
blocked EPSCKA byw60% was used so that a full recov-
ery of the response could be achieved after 30 min of
wash. This w60% block of EPSCKA fully prevented the
induction of LTD (99% 6 8%, n = 7, Figure 4A), demon-
strating that the EPSCKA LTD is sensitive to KAR block-
ade. We also performed a similar experiment using
a subsaturating dose of the selective KAR antagonist,
UBP296 (5 mM; More et al., 2004). This compound also
reversibly blocked EPSCKA and, like CNQX, prevented
EPSCKA LTD (104%6 11%, n = 7, Figure 4B). Thus, syn-
aptic KAR activation is required for induction of this form
of LTD. One possibility is that the KARs themselves gate
the influx of Ca2+ required for the induction of LTD. In
support of this, we found that EPSCKA exhibits an in-
wardly rectifying current-voltage relationship (Figure 4C)
indicative of KARs containing unedited GluR5 and/or
GluR6 that are permeable to Ca2+ (Chittajallu et al.,
1999; Lerma et al., 2001). This, combined with our previ-
ous work showing that GluR5-containing KARs mediate
Ca2+ influx in cultured perirhinal cortical neurons (Cho
et al., 2003), strongly suggests that the primary source
of Ca2+ for the induction of this form of LTD is from the
synaptic KARs themselves.
Tonically Activated mGluR5 Regulates EPSCKA
via PKC
Previous work on perirhinal cortical neurons shows that
mGluRs and PKC can regulate KAR function (Cho et al.,
2003). We next investigated whether these mechanisms
are involved in LTD of KAR-mediated transmission. We
first analyzed the effects of the mGluR5 selective antag-
onist MPEP. Bath application of MPEP (10 mM) caused
a depression in EPSCKA (78%6 6%, n = 6) that occluded
subsequent LTD (93%6 7%, n = 6; Figure 5A). This was
selective for EPSCKA, since EPSCAMPA evoked either by
single shock stimulation or by train stimulation was not
depressed by MPEP (data not shown). The effect of
MPEP indicates that synaptic KAR function is main-
tained by tonic mGluR5 activity and suggests that
mGluR5 is tonically activated by ambient levels of gluta-
mate in the slice. To test this latter idea, we investigated
the effects of manipulating ambient levels of extracellu-
lar glutamate on EPSCKA and LTD. Bath application of
the glutamate transport inhibitor DL-threo-b-benzyloxy-
aspartic acid (TBOA; 5 mM; Shimamoto et al., 1998),
which raises ambient glutamate levels, caused an in-
crease in EPSCKA amplitude (146% 6 9%, n = 8, Fig-
ure 5B) that was completely reversed by subsequent
application of MPEP (89%6 7%, n = 8). We also studied
the effects of reducing extracellular ambient glutamate
concentration using bath application of the enzymic glu-
tamate scavenger system, GPT (glutamic-pyruvic trans-
aminase; 5 units/ml) and pyruvate (2 mM; Overstreet
et al., 1997; Min et al., 1998). This had the opposite effect
to TBOA, causing a depression of EPSCKA amplitude
(82% 6 4% of baseline, n = 8, Figure 5C) that fully oc-
cluded with the effects of subsequent MPEP application
(80% 6 3% of baseline, Figure 5C). In interleaved con-trols, however, application of pyruvate alone caused
no depression in EPSCKA amplitude, and MPEP still re-
liably produced a depression of EPSCKA in its presence
(80% 6 4% of baseline, n = 5, Figure 5D).
These manipulations of ambient glutamate demon-
strate that mGluR5 is tonically activated by glutamate
under our recording conditions and, through this mech-
anism, regulates EPSCKA. These experiments were all
Figure 4. LTD of EPSCKA Requires the Synaptic Activation of Kai-
nate Receptors
(A and B) Application of a subsaturating dose of a KAR antagonist,
CNQX (5 mM; [A]) or UBP (5 mM; [B]) partially blocks EPSCKA but fully
prevents LTD.
(C) Pooled data for I–V relationship of EPSCKA (n = 14). Line is a linear
fit through points at negative potentials. Inset of pharmacologically
isolated EPSCKA traces at the different holding potentials.
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(A) Bath application of the 10 mM MPEP, a selective mGluR5 antagonist, depresses pharmacologically isolated EPSCKA and occludes sub-
sequent LTD.
(B) Bath application of TBOA (5 mM) causes an increase in EPSCKA that is reversed by subsequent MPEP addition.
(C) GPT + pyruvate depresses EPSCKA that occludes with subsequent MPEP application.
(D) Pyruvate alone does not depress EPSCKA, and subsequent MPEP application causes a depression.
(E) EPSCKA LTD is reliably induced by 200 stimuli at 5 Hz at close to physiological temperature.
(F) MPEP depresses EPSCKA at close to physiological temperature that occludes subsequent LTD.performed at 28ºC–30ºC, and, since glutamate transport
is a highly temperature sensitive process, we next inves-
tigated whether this tonic mGluR5-dependent regula-
tion of EPSCKA occurs at close to physiological temper-
ature. In experiments performed at 35ºC, we found that
LTD of EPSCKA could be reliably induced using the 5 Hz
induction protocol (68% 6 4%, n = 7, Figure 5E) and,
moreover, that MPEP reliably caused a depression of
EPSCKA that occluded with LTD (77% 6 3%, n = 6,
Figure 5F). We also tested the effects of bath application
of TBOA at 35ºC; this also caused an increase in EPSCKAamplitude (148% 6 13%, n = 8) that was completely re-
versed by subsequent application of MPEP (data not
shown). Furthermore, consistent with the MPEP data,
AIDA (1-aminoindan-1,5[RS]-dicarboxylic acid), another
selective group I mGluR antagonist (Pellicciari et al.,
1995) also caused a depression in EPSCKA in experi-
ments at this temperature (76% 6 5%, n = 5, data not
shown).
These data demonstrate that mGluR5 is tonically
activated by ambient glutamate levels in the slice and
that this regulates EPSCKA. This regulation persists at
LTD of the KA Receptor-Mediated EPSC
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nism can operate in vivo. We were therefore interested
to determine if there is an ionotropic mGluR5-mediated
current that could be detected in these neurons. To de-
termine if mGluR5 activation causes an increase in
membrane conductance, we measured direct current
(DC) during voltage-clamp recordings in the presence
of picrotoxin, GYKI53633, and D-AP5. No change in
DC was observed with bath application of MPEP at
28ºC or at 35ºC, either using a Cs-based or K-based
whole-cell solution (see Figure S1 in the Supplemental
Data available with this article online). In addition, we
also investigated whether an mGluR5-mediated current
could be evoked by synaptic stimulation at 35ºC.
Five-shock stimulation in the presence of picrotoxin,
GYKI53655, and D-AP5 evoked EPSCKA but did not
evoke any additional mGluR5-mediated current, since
application of CNQX blocked all synaptic current and
subsequent application of MPEP had no further effect
(Figure S2A). Moreover, application of MPEP in the pres-
ence of picrotoxin, GYKI53655, and D-AP5 had no effect
on the evoked EPSC kinetics (Figure S2B), further indi-
cating that there was no mGluR5-dependent compo-
nent to the EPSC. Therefore, in our experiments, no
mGluR5-dependent current was observed.
Previous work shows that PKC can regulate KAR
function (Cho et al., 2003). Thus, we next analyzed the
role of PKC in LTD of EPSCKA using the selective PKC
inhibitory peptide PKC19-31. Inclusion of PKC19-31
(10 mM) in the electrode solution depressed EPSCKA
but not EPSCAMPA (EPSCKA, 68% 6 6%; EPSCAMPA,
98% 6 4%, n = 9; Figure 6A). PKC19-31 also occluded
subsequent LTD in the pharmacologically isolated
EPSCKA (100%6 10%, n = 7, Figure 6B), demonstrating
a requirement for PKC activity in this form of LTD.
PKC19-31 also completely prevented the MPEP-depen-
dent depression in EPSCKA amplitude (in the presence
of PKC19-31, EPSCKA amplitude = 68% 6 6% baseline
before MPEP, 75% 6 6% after MPEP, n = 6, Figure 6C).
Taken together, these findings indicate that a mecha-
nism involving mGluR5 and PKC regulates synaptic
KARs and that this mechanism interacts with the ex-
pression mechanism of EPSCKA LTD.
Blockade of PICK1 PDZ Domain Interactions
Depresses EPSCKA and Prevents LTD
KARs at mossy fiber-CA3 synapses in hippocampus can
be rapidly regulated by interactions with the PDZ do-
main containing protein PICK1 (Hirbec et al., 2003). To
determine whether this interaction is involved in EPSCKA
LTD, we used the peptide pep2-EVKI (YNVYGIEEVKI),
which selectively blocks PICK1 PDZ domain interac-
tions (Li et al., 1999; Daw et al., 2000), including the bind-
ing of PICK1 to the C terminus of the GluR5 and GluR6
KAR subunits (Hirbec et al., 2003). Inclusion of pep2-
EVKI (100 mM) in the intracellular solution caused a rapid
reduction of the KAR-mediated component of the EPSC
(74%6 5%, p < 0.0001, n = 18; Figure 7A). The AMPAR-
mediated component, however, was unaffected by
pep2-EVKI (100% 6 4%, p > 0.5, n = 18, Figure 7A), as
previously shown for hippocampal synapses (Daw
et al., 2000; Hirbec et al., 2003). Furthermore, pep2-
EVKI occluded subsequent induction of EPSCKA LTD(92%6 3%, p > 0.5, n = 6, Figure 7B). In interleaved con-
trol experiments, we tested the effect of pep2-SVKE
(YNVYGIESVKE, 100 mM), an inactive mutant peptide
(Li et al., 1999; Daw et al., 2000). This peptide had no ef-
fect on either AMPAR- or KAR-mediated synaptic trans-
mission (EPSCKA, 96% 6 5%, EPSCAMPA, 98% 6 6%,
n = 10; Figure 7C) and did not prevent EPSCKA LTD
(72%6 3%, n = 7; Figure 7D). The GluR2 and -3 AMPAR
subunits interact with NSF and AP2 at a C-terminal
Figure 6. PKC Regulates EPSCKA
(A) Postsynaptic addition of 10 mM PKC19-31, a membrane-imper-
meable PKC inhibitor, causes a depression of basal EPSCKA (open
symbols) but not EPSCAMPA (filled symbols).
(B) Postsynaptic PKC19-31 depresses EPSCKA in dual component
EPSCs and occludes subsequent LTD of the pharmacologically iso-
lated EPSCKA (filled circles represent test pathway, open circles
control pathway).
(C) Postsynaptic PKC19-31 depresses pharmacologically isolated
EPSCKA that occludes the effect of subsequent MPEP application.
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102Figure 7. EPSCKA LTD Involves the Selective Regulation of EPSCKA by PICK1 PDZ Domain Interactions
(A) Effect of postsynaptic application of pep2-EVKI that selectively blocks PICK1 PDZ domain interactions, on KAR and AMPAR-mediated com-
ponents of the dual component EPSC.
(B) Pooled data and example traces for the effect of pep2-EVKI on LTD of EPSCKA.
(C) Effect of postsynaptic application of pep2-SVKE, an inactive control peptide, on the KAR and AMPA-mediated components of the dual com-
ponent EPSCs.
(D) Postsynaptic inclusion of pep2-SVKE has no effect on 5 Hz-mediated LTD of EPSCKA.
(E) Postsynaptic application of pep2m that blocks interactions with the NSF/AP2 site on GluR2 has no effect on basal EPSCKA but depresses
basal EPSCAMPA.
(F) Postsynaptic inclusion of pep2m has no effect on LTD of EPSCKA.membrane proximal site, in addition to interacting with
PICK and GRIP/ABP via the extreme C-terminal PDZ li-
gand (Collingridge et al., 2004). Since the NSF and AP2
interactions do not occur with KAR subunits, blockade
of these interactions with pep2m (KRMKVAKNAQ)
would be predicted to depress EPSCAMPA as previously
reported (Nishimune et al., 1998; Collingridge et al.,
2004) but not to influence EPSCKA. Consistent with
this, inclusion of pep2m (100 mM) in the recording solu-tion caused a depression of EPSCAMPA (72% 6 5%,
p < 0.005, n = 10; Figure 7E) but had no effect on EPSCKA
(102% 6 3%, p > 0.5, n = 10; Figure 7E). Furthermore,
pep2m had no effect on LTD of EPSCKA (72% 6 1%,
p < 0.001, n = 5; Figure 7F). Thus, synaptic KARs are reg-
ulated differentially from AMPARs in perirhinal cortical
neurons, and this provides the molecular basis for the
mechanistically distinct forms of LTD for AMPAR and
KAR-mediated transmission at this input.
LTD of the KA Receptor-Mediated EPSC
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Although KARs have been shown to be involved in the
induction of LTP at mossy fiber-CA3 synapses in the
hippocampus, a role in either the induction or expres-
sion of LTD has not been reported, despite their post-
synaptic expression at numerous types of input in the
brain (Lerma et al., 2001). Here we now show that
KARs can undergo a form of LTD at synapses on layer
II/III neurons in perirhinal cortex. EPSCKA LTD is mecha-
nistically distinct from LTD of AMPAR-mediated trans-
mission at this input. It has different induction frequency
requirements, and, although it requires a rise in post-
synaptic Ca2+, it does not depend on NMDARs or
low-threshold voltage-gated Ca2+ channels. Rather, it
requires synaptic activation of the KARs, which are in-
wardly rectifying, and release of Ca2+ from intracellular
stores. We further show that EPSCKA is tonically regu-
lated by mGluR5 that is activated by ambient levels of
glutamate. Expression of EPSCKA LTD occludes with this
mGluR5-dependent regulation and involves PKC activ-
ity and PICK1 PDZ domain interactions, mechanisms
that do not regulate AMPARs at the same inputs. Thus,
we describeand characterizea formofactivity-dependent
long-termsynapticplasticityofkainate receptor-mediated
synaptic transmission.
Induction of EPSCKA LTD
LTD of EPSCKA requires a rise in postsynaptic Ca
2+ con-
centration and influx of Ca2+ across the plasma mem-
brane. However, this form of LTD does not require
NMDARs or T-type voltage-gated Ca2+ channels but is
dependent on KAR activation that exhibits inward recti-
fication characteristic of Ca2+-permeable receptors
(Chittajallu et al., 1999; Lerma et al., 2001). This suggests
that it is Ca2+ influx through the synaptic KARs them-
selves that provides the required Ca2+ signal for LTD in-
duction. This idea is supported by our previous work,
which shows that KARs can mediate Ca2+ influx in cul-
tured perirhinal cortical neurons (Cho et al., 2003). We
also show a requirement for release of Ca2+ from intra-
cellular stores for EPSCKA LTD. This suggests that,
during 5 Hz stimulation, Ca2+ influx through the Ca2+-
permable KARs produces release of Ca2+ from stores,
which then leads to the induction of LTD. The extent of
editing of KAR subunits increases with postnatal age,
reducing the Ca2+ permeability of the KAR complement
(Chittajallu et al., 1999). Consistent with this, we find that
EPSCKA LTD is not readily induced by the 5 Hz stimula-
tion protocol in adolescent (>2-week-old) animals (our
unpublished data).
Involvement of other (high-threshold) voltage-gated
Ca2+ channels in mediating the Ca2+ influx is unlikely,
since the neurons are voltage clamped at270 mV during
LTD induction. One possibility, however, is that mGluR5
is involved in the induction, consistent with the finding
that there is an mGluR-dependent form of LTD of
AMPAR-mediated transmission in other brain regions
(e.g., Oliet et al., 1997). Whether mGluR5 is also required
for induction of EPSCKA LTD is difficult to determine,
since blockade of this receptor causes a rundown in
EPSCKA that occludes subsequent LTD.
Our data show that the induction requirements for
LTD of EPSCAMPA at the same inputs are different fromthose for EPSCKA LTD. EPSCAMPA LTD requires NMDAR
activation and can be induced with 1 or 5 Hz stimulation.
In contrast, EPSCKA LTD is independent of NMDARs and
cannot be induced by 1 Hz stimulation, while neither
form is induced by 10 Hz stimulation. Therefore, at the
level of induction mechanisms, LTD of AMPAR and
KAR-mediated transmission at this input are distinct.
EPSCKA LTD seems to require a rather precise fre-
quency of stimulation (5 Hz) and cannot be evoked by
1 or 10 Hz despite using prolonged stimulus trains.
The reason for this precise requirement is unclear and
will be of great interest to determine in future studies.
Expression of EPSCKA LTD
Blockade of mGluR5, PKC, or PICK1 PDZ domain inter-
actions causes a rapid reduction in EPSCKA. This indi-
cates that synaptic KAR function is maintained by
a mechanism involving these proteins during basal
transmission. Indeed, we show a tonic activation of
mGluR5 by ambient levels of glutamate in the slice that
regulates EPSCKA and blockade of which occludes
with the effects of PKC inhibitors. The reduction in
EPSCKA caused by blockade of mGluR5, PKC, or
PICK1 PDZ domain interactions fully occludes EPSCKA
LTD, indicating that these mechanisms all share a com-
mon downstream target that is likely the synaptic KAR
(see Figure 8). One model that is consistent with these
findings is that, during basal transmission, EPSCKA is
maintained by the PICK1-KAR interaction that localizes
PKC to the receptor, thus facilitating an mGluR5-PKC-
dependent phosphorylation of the KAR. In this scenario,
during LTD induction, store Ca2+ release initiated by
synaptic KARs during 5 Hz stimulation causes a disrup-
tion of this mGluR5-PKC-PICK1-dependent mainte-
nance pathway, resulting in the downregulation of syn-
aptic KARs. In support of this hypothesis, the GluR5
KAR subunit C terminus has been shown to be phos-
phorylated by PKC (Cho et al., 2003; Hirbec et al.,
2003), and PKC can upregulate GluR5-containing KAR
function in perirhinal cortical neurons in a mechanism in-
volving mGluR5 activation (Cho et al., 2003). Moreover,
PICK1 dimerizes (Perez et al., 2001) and interacts both
with PKC (Staudinger et al., 1997) and with the C termi-
nus of GluR5 and -6 (Hirbec et al., 2003), providing
a mechanism to localize PKC to KARs. Furthermore, it
has been shown that PICK1-PKC localizes to synapses
following PKC activation (Chung et al., 2000; Perez
et al., 2001). Finally, the PICK interaction with GluR5 is
regulated by Ca2+ (J. Hanley, unpublished data). In this
mechanism, we favor the idea that synaptic KARs are di-
rectly regulated during EPSCKA LTD. However, an alter-
native possibility we cannot exclude is that the LTD
induction protocol causes a reduction in mGluR5 func-
tion which then causes a downstream depression of
EPSCKA due to a reduction in the tonic mGluR5-
dependent maintenance of EPSCKA.
The downregulation of KARs during LTD could be due
to a loss of function of synaptic receptors or a removal of
receptors from the postsynaptic membrane, as has
been proposed for the mechanism of AMPAR LTD
(Kemp and Bashir, 2001; Collingridge et al., 2004). The
loss of function of KARs that remain at the synapse
could be achieved by dephosphorylation of one or
more PKC sites on the C terminus of KAR subunits
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ulation by mGluR5, PKC, and PICK1 PDZ Do-
main Interactions
(A) KAR function is maintained by tonic
mGluR5-stimulated PKC activity during basal
low-frequency transmission through a mech-
anism involving the PICK1-KAR interaction.
(B) Stimulation (5 Hz) leads to large Ca2+
influx through KARs, causing a rapid long-
lasting downregulation of KAR function in
a mechanism that involves the KAR-PICK1 in-
teraction.(Cho et al., 2003; Hirbec et al., 2003). Removal of KARs
from the synaptic membrane could occur due to disrup-
tion of the PICK1-KAR interaction, as has been hypoth-
esized previously (Hirbec et al., 2003). Either mechanism
could produce a depression in EPSCKA, although it
seems more likely that a removal of KARs from the mem-
brane would produce a long-lasting decrease in EPSCKA,
since receptors remaining at the membrane would be
susceptible to rephosphorylation by PKC during low-
frequency transmission following the LTD induction pro-
tocol. It is also possible that a component of the effects
observed on EPSCKA, which has to be evoked by a train
of five stimuli due to the small size of the current, could
be due to actions at a presynaptic locus. However, the
EPSCKA LTD is fully blocked by postsynaptic BAPTA,
or postsynaptic PKC inhibitor, or postsynaptic pep2-
EVKI peptide, strongly suggesting that both the induc-
tion and the expression of LTD are entirely postsynaptic.
Furthermore, we have previously shown the postsyn-
aptic regulation of KAR function by PKC phosphoryla-
tion by group I mGluRs and PKC (Cho et al., 2003), fur-
ther supporting the postsynaptic locus for this form of
plasticity.
Conclusions
LTD of KAR-mediated transmission at this input is dis-
tinct from EPSCAMPA LTD both in its induction require-
ments and expression mechanism. The coexistence of
these two independent LTD mechanisms that can be in-
duced under different conditions provides these inputs
with a unique mechanism to differentially regulate two
different modes of transmission. KAR-mediated trans-
mission enables a large coincidence detection window
but poorly transmits high-frequency afferent activity,
while AMPAR-mediated transmission reliably transmits
high-frequency information but has a small window for
coincidence detection (Frerking and Ohliger-Frerking,
2002). The coexistence of both modes of transmission
at the same inputs, combined with their differential ac-
tivity-dependent regulation, thus provides a mechanism
to allow these inputs to rapidly and long-lastingly switch
their mode of transmission.
Experimental Procedures
Slice Preparation
Slices of perirhinal cortex were prepared from neonatal (7- to
12-day-old) Wistar rats as previously described (Cho et al., 2000,
2003). Animals were sacrificed with dislocation of neck and decap-
itated, and the brain was rapidly removed and placed in ice-cold ar-
tificial cerebrospinal fluid (aCSF; bubbled with 95% O2/5% CO2)comprised of the following: (mM) NaCl, 124; KCl, 3; NaHCO3, 26;
NaH2PO4, 1.25; CaCl2, 2; MgSO4, 1; D glucose, 10. A midsagittal sec-
tion was made, and the rostral and caudal parts of the brain were
removed by single scalpel cuts made at approximately 45º to the
dorsoventral axis and each half glued by its caudal end to a vibroslice
stage (Leica, Nussloch, Germany). Slices (400 mm) that included
perirhinal, entorhinal, and temporal cortices were stored submerged
in aCSF (20ºC–25ºC) for 1–2 hr before transferring to the recording
chamber. A single slice was placed in a submerged recording cham-
ber (28ºC–30ºC or 35ºC, flow rate w2 ml min21) when required. All
antagonists were made up as a stock solution and diluted to their
final appropriate concentration when required.
Electrophysiological Recordings
Whole-cell recordings at 30ºC were made from layer II/III neurons in
perirhinal cortex (Cho et al., 2000, 2003). Stimulating electrodes were
placed either side of the rhinal sulcus. One stimulating electrode was
placed dorsorostrally on the temporal cortex side (area 35/36) and
one ventrocaudally on the entorhinal cortex side (area 35/entorhinal
cortex) of the rhinal sulcus. Stimuli (constant voltage) were delivered
alternately to the two electrodes (each electrode 0.016 Hz). Whole-
cell recordings pipette (4–7 MU) solutions (280 mOsm [pH 7.2]) com-
prised (mM) CsMeSO4, 130; NaCl, 8; Mg-ATP, 4; Na-GTP, 0.3; EGTA,
0.5; HEPES 10; QX-314, 6. In the experiments described in
Figure S1C, a potassium-based whole-cell solution was used as pre-
viously described (Cho et al., 2000). Neurons were voltage clamped
at 270 mV. Data were recorded using an Axopatch 200B amplifier
(Axon Instruments, Foster City, California). EPSC amplitude, series
resistance, input resistance, and DC were monitored and analyzed
online and offline using the LTP program (Anderson and Colling-
ridge, 2001). Series resistance was calculated by estimating the
peak of the unfiltered whole-cell capacitance transient in response
to a 2 mV hypopolarizing step throughout the experiments, and
pipette capacitive transients were compensated for prior to break-
through (Daw et al., 2000). Only cells with series resistance <25 MU
with a change in series resistance <10% from the start were in-
cluded in this study. The amplitude of the excitatory postsynaptic
currents (EPSCs) was measured and expressed relative to the nor-
malized preconditioning baseline. All experiments were carried out
in the presence of 20 mM picrotoxin. In some experiments, the
AMPA receptor antagonist GYKI53655 (50 mM), the NMDA receptor
antagonist D-AP5 (50 mM), the AMPA/KAR antagonist CNQX (25 or
5 mM), and the GluR5 selective antagonist UBP296 (5 mM) were
used where indicated in figures. In experiments in which BAPTA
was infused into the cells, at least 20 min of dialysis was allowed be-
fore the LTD protocol was applied. In experiments in which a peptide
was infused into cells, 30 min of dialysis was allowed prior to LTD
induction, and care was taken in the interleaved experiments with
the control peptide that the same dialysis time was used as for
the active peptides. Picrotoxin, AP5, CNQX, TBOA, and pep2m
were purchased from Tocris (Bristol, United Kingdom). PKC19-31
was purchased from Calbiochem (California). UBP296 was provided
by Dr. David Jane (University of Bristol, United Kingdom), but it is
also available from Tocris. Pep2-EVKI and pep2-SVKE were custom
synthesized (Sigma) with purity higher than 98%. GPT and pyruvate
were also purchased from Sigma. Data were collected from only
from one slice per rat. Data pooled across experiments are ex-
pressed as the mean6 SEM, and effects of conditioning stimulation
LTD of the KA Receptor-Mediated EPSC
105were measured between 20 and 25 min after induction of LTD. Sig-
nificance was tested using the Student’s two-tailed t test (p < 0.05
considered significant).
Supplemental Data
Supplemental Data include two figures and can be found with
this article online at http://www.neuron.org/cgi/content/full/49/1/
95/DC1/.
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